Amgen and Regeneron both pay dividends but cater to different retiree needs: Amgen provides a higher, steadily increasing dividend yield of about 2.16%, suitable for retirees needing income now. Regeneron offers a smaller dividend yield of 0.41% but shows faster revenue growth and a stronger balance sheet with no debt, appealing to investors focused on long-term capital gains. Amgen's dividend is well-covered by cash flow despite its debt, while Regeneron prioritizes buybacks and growth. Investors should choose Amgen for immediate income and Regeneron for growth potential over time.
As of Nov 11, 2026 01:31 WIB, Amgen (AMGN) trades at USD 463.96 with a dividend yield of 2.17% on Pluang, showing a slight 0.27% decline in one day. Regeneron (REGN) is priced higher at USD 907.88 but offers a lower dividend yield of 0.41%, with a 1.31% drop in the same period. Both stocks see 100% buy order activity on Pluang, highlighting investor interest despite recent price dips.
New independent analyses presented by Amgen show that Repatha (evolocumab) is highly cost-effective for high-risk patients without prior heart attack or stroke, reducing major cardiovascular events by up to 29%. The VESALIUS-CV trial data demonstrate...
Amgen has increased its quarterly dividend from $0.28 in 2011 to $2.52 in 2026, representing an 800% growth over 15 years. The company’s dividend raises have slowed recently but remain supported by strong cash flow and reduced share count. With divid...
